Optimizing antibiotic therapy of group IV community-acquired pneumonia patients.

QR Code

Optimizing antibiotic therapy of group IV community-acquired pneumonia patients.

The aim of the study was to evaluate the clinical and economical effectiveness of differentiated antibacterial therapy of group IV patients with community-acquired pneumonia (CAP). Materials and methods. 42 patients, admitted to the hospital with severe CAP without risk factors for P. aeruginosa inf...

Full description

Saved in:

Bibliographic Details
Main Author:	Ya. O. Dziublyk
Format:	Article
Language:	English
Published:	Dnipro State Medical University 2014-06-01
Series:	Medičnì Perspektivi
Subjects:	community-acquired pneumonia antibiotics effectiveness of treatment cost
Online Access:	https://journals.uran.ua/index.php/2307-0404/article/view/28317
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01)

Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia
by: A. A. Taube, et al.
Published: (2023-11-01)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)

Discussion questions about community-acquired pneumonia in children
by: N. A. Geppe, et al.
Published: (2014-03-01)

Retrospective Analysis of the Initial Empirical Antibiotic Therapy Effectiveness for Community-Acquired Pneumonia in Young Individuals in Moscow Multidisciplinary Hospital
by: O. V. Muslimova, et al.
Published: (2022-12-01)

THE ANALYSIS OF THE COMMUNITY-ACQUIRED PNEUMONIA COURSE IN CHILDREN OF ROSTOV-ON-DON
by: O. E. Semernik, et al.
Published: (2019-03-01)

Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital
by: Rohayat Bilmahdi Simanjuntak, et al.
Published: (2024-04-01)

The Practice of Antibiotic Therapy of Severe Community-Acquired Pneumonia in Adults in Russian Multidisciplinary Hospitals
by: S. A. Rachina, et al.
Published: (2022-04-01)

Use of medications in children hospitalized with community-acquired pneumonia
by: D. D. Siukaeva, et al.
Published: (2018-11-01)

Study of the clinical profile of community-acquired pneumonia: a cross-sectional study in northeast India
by: Annu Gupta, et al.
Published: (2025-06-01)

Inhaled Polymyxin in Treatment of Elderly Patients with Severe Community-Acquired Klebsiella pneumoniae-Induced Pneumonia
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit
by: Yu. V. Evsutina
Published: (2021-06-01)

Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
by: N. V. Iziurova, et al.
Published: (2024-01-01)

The Role of Ultrasound in Diagnosing Community-Acquired Pneumonia
by: D. O. Starostin, et al.
Published: (2023-02-01)

Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)

Barriers to Compliance with National Guidelines Among Children Hospitalized with Community-Acquired Pneumonia in Vietnam and the Implications
by: Thuy Thi Phuong Nguyen, et al.
Published: (2025-07-01)

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA
by: L. R. Mukhamadieva, et al.
Published: (2014-07-01)

Modern approaches at the management of children with community-acquired pneumonia
by: Aleksander A. Baranov, et al.
Published: (2023-03-01)

The Effect of Selective and Mass Immunization Against Pneumococcal Infection on the Morbidity and Mortality due to Community-Acquired Pneumonia in Children Under 5 Years of Age
by: Vadislav V. Semerikov, et al.
Published: (2019-12-01)

THE CLINICAL, EPIDEMIOLOGICAL AND MICROBIOLOGICAL PATTERN OF COMMUNITY-ACQUIRED PNEUMONIA IN THE KARACHAY-CHERKESS REPUBLIC
by: Palina Khalitovna Katchieva, et al.
Published: (2022-10-01)

Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People
by: T. V. Alexandrova, et al.
Published: (2022-07-01)

MULTILOCI SEQUESTERANT STRAINS OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM ELDERLY PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by: A. V. Martynova, et al.
Published: (2014-06-01)

Role of Inflammatory Markers as a Risk Factor for Community-Acquired Pneumonia Management
by: Ruta Nutautiene, et al.
Published: (2025-06-01)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
by: L. A. Demidchik, et al.
Published: (2016-05-01)

Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis
by: Diego Viasus, et al.
Published: (2025-07-01)

New Antibiotics for Lower Respiratory Tract Infections
by: Despoina Papageorgiou, et al.
Published: (2025-06-01)

Effect of vaccination on morbidity and mortality from community-acquired pneumonia
by: T. A. Bayanova, et al.
Published: (2024-03-01)

Community-acquired pneumonia: risk factors, prognosis, microbial etiology, treatment, and prophylaxis
by: Catia Cilloniz, et al.
Published: (2025-04-01)

Comparative Analysis of the Pathogen Structure in Patients with Community-Acquired and Nosocomial Pneumonia in Medical Organizations of the Rostov, Tyumen Regions and Khabarovsk Territory at the Current Stage of a New Coronavirus Infection Pandemic
by: N. V. Pavlovich, et al.
Published: (2023-10-01)

Central Hemodynamics and Extravascular Lung Water Index in Varying Degrees of Community-Acquired Pneumonia
by: S. N. Avdeykin, et al.
Published: (2015-09-01)

Problems of assessing the severity of the state of elderly patients with community-acquired pneumonia caused by Klebsiella pneumoniae
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Features of the clinical presentation and course of community-acquired pneumonia against the background of type 2 diabetes mellitus
by: A. A. Zaytseva, et al.
Published: (2022-07-01)

Prognostic value of peripheral blood lymphocytes in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2025-06-01)

Calculation of epidemic thresholds for incidence of community-acquired pneumonia
by: A. D. Botvinkin, et al.
Published: (2022-06-01)

Cytokine profile of bronchoalveolar secretion in prolonged course of community acquired pneumonia
by: R.V. Razumnyi
Published: (2022-03-01)

Assessment of the prognosis of the outcome of severe community-acquired pneumonia caused by <i>Klebsiella pneumoniae</i>
by: V. I. Sakharov, et al.
Published: (2023-12-01)

Platelet variables in community-acquired pneumonia in children with respiratory infections
by: E. A. Kozyrev, et al.
Published: (2022-04-01)

Effectiveness of β-lactam and Macrolide Antibiotic Combination in Patients with Community-Acquired Pneumonia: A Review
by: Nurul Hikmah, et al.
Published: (2025-06-01)